Medimmune, of Gaithersburg, Md., the global biologics research and development arm of Astrazeneca plc, and the University System of Maryland said that the initial research collaboration between MedImmune and the University of Maryland, Baltimore (UMB) has been expanded to include the University of Maryland, College Park and the University of Maryland, Baltimore County.